Viability testing in ischemic cardiomyopathy: concepts, caveats and case illustrations

-Focus on the reduced role of viability testing in the setting of STICH trial viability substudy. Possible hypotheses for the failure of viability testing.
-Global revascularization is best performed regardless of viability testing.
-Viability testing may have a role in guiding regional revascularization, particularly when PCI is chosen
-Viability testing may have a role when single vessel CTO PCI is considered for HF purposes.
-Role of Q waves

[@MohammadIbrahim-bx3zj]

Excellent and precious presentation demystified the viability rules

[@moustafakamalsaad2293]

thank you very much for this excellent presentation

[@kerolusshehata2275]

Thank you for the great presentation.

[@TvAanimalia]

Excellent stuff...thank You very muuch

[@husseinghannam4315]

Great job

[@HealthwithAamir]

Such an amazing presentation thank you sir

[@DrSaidAbdirahmanCardiologist]

Thanks it was so usefull for young cardiologist❤

[@UsoppTheProud]

Thank You for the wonderful lecture
There is a new trial called Revived trial which showed PCI does not change hard outcomes (death and hospitalization) in ischemic cardiomyopathy

[@eliashanna8248]

Thank you. You can review my take on the REVIVED BCIS trial under my online book updates: sites.google.com/view/elias-hanna-book-updates/home

[@ivanmr6873]

​@@eliashanna8248thank you for your lectures and input, sir

[@syasyazainal6191]

Also i thought there are data showing if revascularization is performed in non viable segments patient tend to do worse? Please correct me